158435-41-7Relevant articles and documents
Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation
Smith, Thomas P.,Windsor, Ian W.,Forest, Katrina T.,Raines, Ronald T.
, p. 7820 - 7834 (2017/10/06)
Transthyretin (TTR) is a homotetrameric protein. Its dissociation into monomers leads to the formation of fibrils that underlie human amyloidogenic diseases. The binding of small molecules to the thyroxin-binding sites in TTR stabilizes the homotetramer and attenuates TTR amyloidosis. Herein, we report on boronic acid-substituted stilbenes that limit TTR amyloidosis in vitro. Assays of affinity for TTR and inhibition of its tendency to form fibrils were coupled with X-ray crystallographic analysis of nine TTR·ligand complexes. The ensuing structure-function data led to a symmetrical diboronic acid that forms a boronic ester reversibly with serine 117. This diboronic acid inhibits fibril formation by both wild-type TTR and a common disease-related variant, V30M TTR, as effectively as does tafamidis, a small-molecule drug used to treat TTR-related amyloidosis in the clinic. These findings establish a new modality for covalent inhibition of fibril formation and illuminate a path for future optimization.
2- PYRIDONE COMPOUND
-
Paragraph 0353; 0354, (2016/10/08)
PROBLEM TO BE SOLVED: To provide a compound that has excellent glucokinase (GK) activating action and is useful as a pharmaceutical. SOLUTION: The present invention provides a 2-pyridone compound represented by formula [1], and a tautomer or stereoisomer of the compound, or their pharmacologically acceptable salts, or their solvates (where R1 is RA-ZA-; RA is any of a carboxy group, a sulfo group or formula [5]). COPYRIGHT: (C)2016,JPOandINPIT
A new oxidovanadium(IV) complex containing an O, N-bidentate Schiff base ligand: Synthesis, characterization, crystal structure determination, thermal study and catalytic activity for an oxidative bromination reaction
Grivani, Gholamhossein,Tahmasebi, Vida,Khalaji, Aliakbar Dehno
, p. 144 - 150 (2013/12/04)
A new oxidovanadium(IV) schiff base complex (1) containing an ethyl bromide pendant group was synthesized by the reaction of the related bidentate O, N-Schiff base ligand and VO(acac)2 in a 2:1 ratio in methanol, under reflux conditions. The Schiff base ligand and its vanadyl Schiff base complex were characterized by 1H NMR and FT-IR spectra, and CHN analysis. The crystal structure of 1 was also determined by single crystal X-ray analysis. The vanadium center in this structure has a distorted tetragonal pyramidal N2O3 coordination sphere. The Schiff base ligand HL acts as a bidentate ligand by coordinating via the nitrogen atom of the imine group and the oxygen atom of the phenolic group, thereby forming a six-membered chelating ring. There are some non-classical inter- and intra-molecular hydrogen bonds of the type C-Ha?O and C-Ha?Br in 1. The catalytic activity of 1 was studied for the oxidative bromination of 2-nitrophenol as a model substrate. Different reaction parameters were studied in this reaction and the oxidative bromination of some organic compounds by a catalytic amount of 1 showed that it was an effective and selective catalyst under optimal conditions. Thermogravimeric analysis of 1 showed that it decomposed in two stages. In addition, complex 1 thermally decomposed in air at 660 C and the XRD pattern of the obtained solid showed the formation of V2O5 nanoparticles with an average size of 57 nm.
